<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.2 20060430//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id><journal-title>BMC Cancer</journal-title><issn pub-type="epub">1471-2407</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2407-6-243</article-id><article-id pub-id-type="pmid">17029639</article-id><article-id pub-id-type="doi">10.1186/1471-2407-6-243</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of <italic>NTHL1</italic>, <italic>NEIL1</italic>, <italic>NEIL2</italic>, <italic>MPG</italic>, <italic>TDG</italic>, <italic>UNG </italic>and <italic>SMUG1 </italic>genes in familial colorectal cancer predisposition</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Broderick</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>peter.broderick@icr.ac.uk</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Bagratuni</surname><given-names>Tina</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>tina.bagratuni@icr.ac.uk</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Vijayakrishnan</surname><given-names>Jairam</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jairam.vijayakrishnan@icr.ac.uk</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Lubbe</surname><given-names>Steven</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>steven.lubbe@icr.ac.uk</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Chandler</surname><given-names>Ian</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ian.chandler@icr.ac.uk</email></contrib><contrib id="A6" corresp="yes" contrib-type="author"><name><surname>Houlston</surname><given-names>Richard S</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>richard.houlston@icr.ac.uk</email></contrib></contrib-group><aff id="I1"><label>1</label>Section of Cancer Genetics, Brookes Lawley Building, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>9</day><month>10</month><year>2006</year></pub-date><volume>6</volume><fpage>243</fpage><lpage>243</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/6/243"/><history><date date-type="received"><day>9</day><month>6</month><year>2006</year></date><date date-type="accepted"><day>9</day><month>10</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 Broderick et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Broderick et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Broderick Peter peter.broderick@icr.ac.uk </dc:author><dc:title> Evaluation of NTHL1, NEIL1, NEIL2, MPG, TDG, UNG and SMUG1 genes in familial colorectal cancer predisposition </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>BMC Cancer 6(1): 243-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2407(2006)6:1&#x0003c;243&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2407</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>The observation that germline mutations in the oxidative DNA damage repair gene <italic>MUTYH </italic>cause colorectal cancer (CRC) provides strong evidence that dysregulation of the base excision repair (BER) pathway influences disease susceptibility. It is conceivable that germline sequence variation in other BER pathway genes such as <italic>NTHL1</italic>, <italic>NEIL1</italic>, <italic>NEIL2</italic>, <italic>MPG</italic>, <italic>TDG</italic>, <italic>UNG </italic>and <italic>SMUG1 </italic>also contribute to CRC susceptibility.</p></sec><sec sec-type="methods"><title>Methods</title><p>To evaluate whether sequence variants of <italic>NTHL1</italic>, <italic>NEIL1</italic>, <italic>NEIL2</italic>, <italic>MPG</italic>, <italic>TDG</italic>, <italic>UNG </italic>and <italic>SMUG1 </italic>genes might act as CRC susceptibility alleles, we screened the coding sequence and intron-exon boundaries of these genes in 94 familial CRC cases in which involvement of known genes had been excluded.</p></sec><sec><title>Results</title><p>Three novel missense variants were identified <italic>NEIL2 </italic>C367A, <italic>TDG3 </italic>A196G and <italic>UNG2 </italic>C262T in patients, which were not observed in 188 healthy control DNAs.</p></sec><sec><title>Conclusion</title><p>We detected novel germline alterations in <italic>NEIL2, TDG </italic>and <italic>UNG </italic>patients with CRC. The results suggest a limited role for <italic>NTHL1</italic>, <italic>NEIL1</italic>, <italic>NEIL2</italic>, <italic>MPG</italic>, <italic>TDG</italic>, <italic>UNG </italic>and <italic>SMUG1 </italic>in development of CRC.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>A recent twin study indicates that approximately a third of all colorectal cancers (CRC) involve an inherited predisposition [<xref ref-type="bibr" rid="B1">1</xref>]. Germline mutations in the known CRC genes (<italic>APC</italic>, mismatch repair (MMR) genes, <italic>MUTYH/MYH</italic>, <italic>SMAD4</italic>, <italic>ALK3 </italic>and <italic>STK11/LKB1</italic>) do not, however, account for all of the familial risk of the disease. The observation that mutations in <italic>MUTYH </italic>predispose to CRC [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]has provided strong evidence that dysregulation of the base excision repair (BER) pathway contributes to disease susceptibility. MUTYH functions as a DNA glycosylase responsible for excision of adenines mis-incorporated opposite 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxoG), a stable product of oxidative DNA damage [<xref ref-type="bibr" rid="B4">4</xref>]. The BER pathway plays a pivotal role in protecting against oxidative DNA damage and is especially relevant in colorectum, which is characterised by high levels of oxygen radicals generated by bacteria and dietary carcinogens [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>].</p><p>In addition to MUTYH a number of other DNA glycosylases participate in BER. These include endonuclease III-like 1 (<italic>NTHL1</italic>, MIM 602556) which acts on oxidized pyrimidine residues; endonuclease VIII-like 1 (<italic>NEIL1</italic>, MIM 608844) and endonuclease VIII-like 2, (<italic>NEIL2</italic>, MIM 608933) which initiate the first step in BER by cleaving reactive oxygen species (ROS) damaged bases; N-methylpurine DNA glycosylase (<italic>MPG</italic>; MIM 156565) which removes a diverse group of damaged bases, including cytotoxic and mutagenic alkylation adducts of purine; thymine-DNA glycosylase (<italic>TDG</italic>, MIM 601423) which initiates repair of G/T and G/U mismatches, commonly associated with CpG islands, by removing thymine and uracil moieties; uracil-DNA glycosylase (<italic>UNG</italic>, MIM 191525) which removes uracil in DNA resulting from deamination of cytosine or replicative incorporation of dUMP, and single-strand-selective monofunctional uracil-DNA glycosylase 1 (<italic>SMUG1</italic>; MIM 607753) which removes uracil from single- and double-stranded DNA in nuclear chromatin.</p><p>To evaluate whether germline variants of <italic>NTHL1</italic>, <italic>NEIL1</italic>, <italic>NEIL2</italic>, <italic>MPG</italic>, <italic>TDG</italic>, <italic>UNG </italic>and <italic>SMUG1 </italic>genes might act as CRC susceptibility alleles, we have screened the coding sequence and intron-exon boundaries of these genes in 94 familial CRC cases.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Ascertainment of cases and controls</title><p>Study subjects were ascertained as part of the National Study of Colorectal Cancer (NSCCG). Details of the NSCCG study design are available online [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. Briefly, the NSCCG was established in March 1999 and is an ongoing study to investigate the role of genetic factors in the aetiology of CRC. To date over 6,000 cases with histologically verified adenocarcinoma of the colon or rectum have been recruited from clinics throughout the United Kingdom. A standardised questionnaire was used to collect phenotypic and family history information from cases and all were asked to provide blood samples for the extraction of DNA. The current study is based on CRC cases that reported family history of CRC in at least one first-degree relative. The 94 cases with the earliest age of CRC were selected. No cases carried biallelic <italic>MUTYH </italic>mutations or a truncating mutation in <italic>APC </italic>(associated with familial adenomatous polyposis). Germline mismatch repair gene mutations were excluded by microsatellite instability testing (BAT25, BAT26) in archival tumour specimens. Although not totally comprehensive it provides a relatively robust method of excluding inherited MMR mutations. Controls were cancer free individuals who were spouses or friends of cancer cases selected to match the sex and age of the cases as closely as possible. All study subjects were Caucasian of British ancestry and current UK residents. Genomic DNA was extracted and quantified from the venous blood samples by standard methods.</p><p>Informed consent was obtained from all participants and the study was undertaken with local ethical board approval in accordance with the tenets of the Helsinki Declaration.</p></sec><sec><title>Mutational analysis</title><p>The coding regions and intron-exon boundaries of <italic>NTHL1</italic>, <italic>NEIL1</italic>, <italic>NEIL2</italic>, <italic>MPG</italic>, <italic>TDG</italic>, <italic>UNG </italic>and <italic>SMUG1 </italic>were PCR amplified. Amplifying primers were designed using the genomic sequence for each gene [<xref ref-type="bibr" rid="B9">9</xref>] in conjunction with Primer3 software [<xref ref-type="bibr" rid="B10">10</xref>]. Primer sequences and PCR conditions for each gene are detailed in Table <xref ref-type="table" rid="T3">3</xref>. PCR products were hybridised and heteroduplexes assayed for small intragenic mutations by conformation sensitive gel electrophoresis (CSGE) [<xref ref-type="bibr" rid="B11">11</xref>]. Genomic DNA from cases showing mobility shifts was sequenced using the BigDyeTerminator Cycle Sequencingkit and a 3730xl automated sequencer (Applied Biosystems, Foster City, USA). All mutations were confirmed by sequencing at least two independent PCR products.</p></sec><sec><title>Bio-informatics analysis</title><p>We applied two <italic>in silico </italic>algorithms, the PolyPhen algorithm [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>] and the SIFT algorithm [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>], to predict the putative impact of missense variants on protein function.</p></sec></sec><sec><title>Results</title><p>DNAs from the 94 familial CRC without germline mutations in the known CRC predisposition loci were screened for sequence variants in <italic>NTHL1</italic>, <italic>NEIL1</italic>, <italic>NEIL2</italic>, <italic>MPG</italic>, <italic>TDG</italic>, <italic>UNG </italic>and <italic>SMUG1</italic>. The average age at diagnosis of CRC in the cases was 54.8 years (SD, 9.3 years; median age 56 years). Of the cases 59 had been diagnosed with colonic disease and 54 were male.</p><p>In total 22 sequence variants were identified (Table <xref ref-type="table" rid="T2">2</xref>). Eleven of the variants were detected in intronic (not involving consensus splice sites) or untranslated regions. One variant, rs5745908 maps to the second base of the donor splice site in intron 1 of <italic>NEIL1</italic>. Of these twelve variants, ten have been previously reported as polymorphisms (sequence variants with minor allele frequency greater or equal to 1%) in the dbSNP database [<xref ref-type="bibr" rid="B16">16</xref>]. On the basis of the likely absence of effect on protein function and the fact that most were seen in multiple cases, we consider it unlikely that these intronic variants represent high-risk CRC cancer susceptibility alleles. Therefore, these were not additionally investigated. Ten exonic variants were identified. None of the variants caused translational frameshifts or nonsense codons and three were synonymous (i.e. maintaining the amino acid sequence of the translated protein; Table <xref ref-type="table" rid="T2">2</xref>). Of the three synonymous variants, two were known polymorphisms documented in dbSNP and only one was a novel change. Seven non-synonymous changes were identified and of these four were documented in dbSNP as polymorphisms. To investigate the population frequency of the three novel missense alterations identified in single unrelated cases (<italic>NEIL2 </italic>C367A, <italic>TDG3 </italic>A196G and <italic>UNG2 </italic>C262T) the relevant exons were screened in 188 cancer-free controls. None of these variants were detected in the controls. The three novel missense variants detected in familial CRC cases were predicted to be probably damaging by both the Polyphen and SIFT algorithms. <italic>NEIL2 </italic>C367A was detected in a 65-year-old male with CRC. The individual's brother, sister and nephew had also been diagnosed with CRC. Variant <italic>TDG3 </italic>A196G was identified in a 66-year-old male with rectal cancer. The patient's sister died of CRC at age 47. Variant <italic>UNG2 </italic>C262T was identified in a male with colonic cancer diagnosed at age 53 whose mother and maternal aunt had CRC diagnosed at age 77 and 72 respectively. Unfortunately for reasons of clinical governance we were not in a position to evaluate tumour blocks from relatives to test for segregation of alleles.</p></sec><sec><title>Discussion</title><p>We have sought to identify pathogenic germline mutations in seven genes encoding components of the BER system. To empower our analysis we have studied familial cases in which involvement of the known CRC predisposition genes has been excluded. In ascertaining familial cases we have relied on reported information. While inaccuracy in reported family histories is a theoretic limitation, studies have shown that cancers such as CRC are generally reliably reported in first-degree relatives [<xref ref-type="bibr" rid="B17">17</xref>].</p><p>While MYH associated polyposis is an autosomal recessive disease we purposely did not restrict our analysis to individuals with these phenotypes as there is no evidence <italic>a priori </italic>that mutations in other BER will operate in a similar fashion, hence it is appropriate to consider all models of inheritance. None of the patients studied harboured clearly pathogenic biallelic sequence variants, nor was there strong evidence that any single variant was disease causing.</p><p>We cannot exclude the possibility that a minority of mutations have been missed, but under test conditions we have found that CSGE can detect all small insertions or deletions and 70% of single base substitutions. Here the technique detected a number of single base substitution polymorphisms hence there is over a 90% probability that an allele conferring a 2-fold increase in CRC risk with a population frequency = 1% will have been identified through screening the 94 familial cases. Based on the number of patients we have screened for constitutive mutations we can conclude with 95% probability that germline variation in any of these genes will at best not account for more than 3% of all familial CRCs in the British population (upper 95% confidence interval of point estimate).</p><p>We detected a number of novel germline alterations in <italic>NEIL2, TDG, UNG </italic>genes in patients with CRC. Three novel missense variants detected in familial CRC cases were predicted to be probably damaging by both the Polyphen and SIFT algorithms. While these algorithms have been demonstrated in benchmarking studies to successfully categorise 80% of amino acid substitutions [<xref ref-type="bibr" rid="B18">18</xref>], predictions about the functional consequences of amino acid changes are not definitive and require validation in functional assays. Overall results suggest at best a limited role for these variants in predisposition.</p><p>The substrates of the BER glycosylases overlap and therefore there is functional redundancy within the oxidative DNA damage repair system. On this basis it is perhaps not surprising that we did not identify disease causing mutations in our study. Such an assertion does not however, take into account the fact that mutation of <italic>MUTYH </italic>is causative of CRC. Finally, our current analyses do not exclude the possibility that sequence variants in the genes we analysed are associated with low penetrance CRC susceptibility. Evaluation of this hypothesis will require additional studies comparing the frequency of gene sequence variants in large series of CRC cancer cases and healthy controls.</p></sec><sec><title>Conclusion</title><p>We report here the first <italic>NEIL2, TDG, UNG </italic>germline alterations in patients with CRC. However, the rarity of such alterations suggests a limited role for sequence variation in defining predisposition. Notwithstanding, germline variants in these genes do exist and may be associated with susceptibility, but further studies including functional analyses are needed for confirmation.</p></sec><sec><title>Abbreviations</title><p>APC, adenomatosis polyposis coli; BER, base excision repair; CRC, colorectal cancer; CSGE, conformation sensitive gel electrophoresis; MMR, mismatch repair; MPG, N-@methylpurine DNA glycosylase; MUTYH, MutY, E.coli, homolog of; NEIL1, endonuclease VIII-like 1; NEIL2, endonuclease VIII-like 2; NSCCG, National Study of Colorectal Cancer; NTHL1, endonuclease III-like 1; ROS, reactive oxygen species; SMUG1, single-strand-selective monofunctional uracil-dna glycosylase 1; TDG, thymine-DNA glycosylase; UNG, uracil-DNA glycosylase</p></sec><sec><title>Competing interests</title><p>The author(s) declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>PB, TB, JV, SL and IC carried out the genetic studies. PB and RSH were responsible for drafting and revising the manuscript. PB and RSH were involved in design of the study, providing important intellectual content and acquisition of the study material. All authors read and approved the final manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/6/243/prepub"/></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We are grateful to all the study participants and their clinicians. Funding for this work was supported by grants from Cancer Research UK. The NSCCG is supported by NCRN (National Cancer Research Network) and CORE.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>P</given-names></name><name><surname>Holm</surname><given-names>NV</given-names></name><name><surname>Verkasalo</surname><given-names>PK</given-names></name><name><surname>Iliadou</surname><given-names>A</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Koskenvuo</surname><given-names>M</given-names></name><name><surname>Pukkala</surname><given-names>E</given-names></name><name><surname>Skytthe</surname><given-names>A</given-names></name><name><surname>Hemminki</surname><given-names>K</given-names></name></person-group><article-title>Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland</article-title><source>N Engl J Med</source><year>2000</year><volume>343</volume><fpage>78</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">10891514</pub-id><pub-id pub-id-type="doi">10.1056/NEJM200007133430201</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Al-Tassan</surname><given-names>N</given-names></name><name><surname>Chmiel</surname><given-names>NH</given-names></name><name><surname>Maynard</surname><given-names>J</given-names></name><name><surname>Fleming</surname><given-names>N</given-names></name><name><surname>Livingston</surname><given-names>AL</given-names></name><name><surname>Williams</surname><given-names>GT</given-names></name><name><surname>Hodges</surname><given-names>AK</given-names></name><name><surname>Davies</surname><given-names>DR</given-names></name><name><surname>David</surname><given-names>SS</given-names></name><name><surname>Sampson</surname><given-names>JR</given-names></name><name><surname>Cheadle</surname><given-names>JP</given-names></name></person-group><article-title>Inherited variants of MYH associated with somatic G:C--&#x0003e;T:A mutations in colorectal tumors</article-title><source>Nat Genet</source><year>2002</year><volume>30</volume><fpage>227</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">11818965</pub-id><pub-id pub-id-type="doi">10.1038/ng828</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sieber</surname><given-names>OM</given-names></name><name><surname>Lipton</surname><given-names>L</given-names></name><name><surname>Crabtree</surname><given-names>M</given-names></name><name><surname>Heinimann</surname><given-names>K</given-names></name><name><surname>Fidalgo</surname><given-names>P</given-names></name><name><surname>Phillips</surname><given-names>RK</given-names></name><name><surname>Bisgaard</surname><given-names>ML</given-names></name><name><surname>Orntoft</surname><given-names>TF</given-names></name><name><surname>Aaltonen</surname><given-names>LA</given-names></name><name><surname>Hodgson</surname><given-names>SV</given-names></name><name><surname>Thomas</surname><given-names>HJ</given-names></name><name><surname>Tomlinson</surname><given-names>IP</given-names></name></person-group><article-title>Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>791</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">12606733</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa025283</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Slupska</surname><given-names>MM</given-names></name><name><surname>Luther</surname><given-names>WM</given-names></name><name><surname>Chiang</surname><given-names>JH</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Miller</surname><given-names>JH</given-names></name></person-group><article-title>Functional expression of hMYH, a human homolog of the Escherichia coli MutY protein</article-title><source>J Bacteriol</source><year>1999</year><volume>181</volume><fpage>6210</fpage><lpage>6213</lpage><pub-id pub-id-type="pmid">10498741</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ames</surname><given-names>BN</given-names></name><name><surname>Gold</surname><given-names>LS</given-names></name></person-group><article-title>Endogenous mutagens and the causes of aging and cancer</article-title><source>Mutat Res</source><year>1991</year><volume>250</volume><fpage>3</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">1944345</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huycke</surname><given-names>MM</given-names></name><name><surname>Gaskins</surname><given-names>HR</given-names></name></person-group><article-title>Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models</article-title><source>Exp Biol Med (Maywood)</source><year>2004</year><volume>229</volume><fpage>586</fpage><lpage>597</lpage><pub-id pub-id-type="pmid">15229352</pub-id></citation></ref><ref id="B7"><citation citation-type="other"><article-title>National Study of Colorectal Cancer Genetics Trial.</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ncrn.org.uk/portfolio/data.asp?ID=1269"/></citation></ref><ref id="B8"><citation citation-type="other"><article-title>Royal Marsden Hospital Trust/Institute of Cancer Research Family History and DNA Registry.</article-title><ext-link ext-link-type="uri" xlink:href="http://intra-test.icr.ac.uk/tissueres/patient_blood.html"/></citation></ref><ref id="B9"><citation citation-type="other"><article-title>University of California Santa Cruz (UCSC) Human Genome Browser</article-title><ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgGateway"/></citation></ref><ref id="B10"><citation citation-type="other"><article-title>Primer3</article-title><ext-link ext-link-type="uri" xlink:href="http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi"/></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>A</given-names></name><name><surname>Rock</surname><given-names>MJ</given-names></name><name><surname>Prockop</surname><given-names>DJ</given-names></name></person-group><article-title>Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes</article-title><source>Proc Natl Acad Sci U S A</source><year>1993</year><volume>90</volume><fpage>10325</fpage><lpage>10329</lpage><pub-id pub-id-type="pmid">8234293</pub-id><pub-id pub-id-type="doi">10.1073/pnas.90.21.10325</pub-id></citation></ref><ref id="B12"><citation citation-type="other"><article-title>Polymorphism Phenotyping (PolyPhen)</article-title><ext-link ext-link-type="uri" xlink:href="http://www.bork.embl-heidelberg.de/PolyPhen/"/></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramensky</surname><given-names>V</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Sunyaev</surname><given-names>S</given-names></name></person-group><article-title>Human non-synonymous SNPs: server and survey</article-title><source>Nucleic Acids Res</source><year>2002</year><volume>30</volume><fpage>3894</fpage><lpage>3900</lpage><pub-id pub-id-type="pmid">12202775</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkf493</pub-id></citation></ref><ref id="B14"><citation citation-type="other"><article-title>Sorting Intolerant from Tolerant (SIFT)</article-title><ext-link ext-link-type="uri" xlink:href="http://blocks.fhcrc.org/sift/SIFT.html"/></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>PC</given-names></name><name><surname>Henikoff</surname><given-names>S</given-names></name></person-group><article-title>Predicting deleterious amino acid substitutions</article-title><source>Genome Res</source><year>2001</year><volume>11</volume><fpage>863</fpage><lpage>874</lpage><pub-id pub-id-type="pmid">11337480</pub-id><pub-id pub-id-type="doi">10.1101/gr.176601</pub-id></citation></ref><ref id="B16"><citation citation-type="other"><article-title>National Center for Biotechnology Information (NCBI) dbSNP Database</article-title><source>[http://wwwncbinlmnihgov/SNP/]; </source></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerber</surname><given-names>RA</given-names></name><name><surname>Slattery</surname><given-names>ML</given-names></name></person-group><article-title>Comparison of self-reported and database-linked family history of cancer data in a case-control study</article-title><source>Am J Epidemiol</source><year>1997</year><volume>146</volume><fpage>244</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">9247008</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname><given-names>T</given-names></name><name><surname>Jones</surname><given-names>IM</given-names></name><name><surname>Mohrenweiser</surname><given-names>HW</given-names></name></person-group><article-title>Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function</article-title><source>Genomics</source><year>2004</year><volume>83</volume><fpage>970</fpage><lpage>979</lpage><pub-id pub-id-type="pmid">15177551</pub-id><pub-id pub-id-type="doi">10.1016/j.ygeno.2003.12.016</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><table-wrap position="float" id="T1"><label>Table 1</label><caption><p><italic>NTHL1</italic>, <italic>NEIL1</italic>, <italic>NEIL2</italic>, <italic>MPG</italic>, <italic>TDG</italic>, <italic>UNG </italic>and <italic>SMUG1 </italic>gnes screened for germline mutations.</p></caption><table frame="hsides" rules="groups"><thead><tr><td><bold>Gene</bold></td><td><bold>Genimic sequence</bold></td><td><bold>cDNA sequence</bold></td><td><bold>No. of exons</bold></td><td><bold>No. of PCR fragements</bold></td></tr></thead><tbody><tr><td align="left"><italic>NTHL1</italic></td><td align="left">NT_037887</td><td align="left">NM_002528.4</td><td align="left">6</td><td align="left">7</td></tr><tr><td align="left"><italic>NEIL1</italic></td><td align="left">NT_010194</td><td align="left">NM_024608.1</td><td align="left">9</td><td align="left">11</td></tr><tr><td align="left"><italic>NEIL2</italic></td><td align="left">NT_077531</td><td align="left">NM_145043.1</td><td align="left">4</td><td align="left">6</td></tr><tr><td align="left"><italic>MPG</italic></td><td align="left">NT_037887</td><td align="left">NM_002434.2</td><td align="left">4</td><td align="left">8</td></tr><tr><td align="left"><italic>TDG</italic></td><td align="left">NT_019546</td><td align="left">NM_003211.3</td><td align="left">10</td><td align="left">12</td></tr><tr><td align="left"><italic>UNG</italic></td><td align="left">NT_009775</td><td align="left">NM_080911.1</td><td align="left">7</td><td align="left">9</td></tr><tr><td align="left"><italic>SMUG1</italic></td><td align="left">NT_029419</td><td align="left">NM_014311.1</td><td align="left">2</td><td align="left">5</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Sequence changes in BER genes in familial colorectal cancer cases and controls</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Gene </bold></td><td align="center"><bold>Exon</bold></td><td align="center"><bold>Nucleotide change</bold></td><td align="center"><bold>Amino acid change</bold></td><td align="center"><bold>No. of heterozygote cases (n = 94)</bold></td><td align="center"><bold>No. of heterozygote controls (n = 188)</bold></td><td align="center"><bold>DbSNP database entry</bold></td></tr></thead><tbody><tr><td align="center"><italic>NEIL1</italic></td><td align="center">IVS1</td><td align="center">T434+2C</td><td></td><td align="center">1</td><td></td><td align="center">rs5745908</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="center"><italic>NEIL2</italic></td><td align="center">IVS1</td><td align="center">T138+25C</td><td></td><td align="center">&#x0003e;10</td><td></td><td align="center">rs804269</td></tr><tr><td></td><td align="center">IVS1</td><td align="center">C138+35T</td><td></td><td align="center">&#x0003e;10</td><td></td><td align="center">rs804268</td></tr><tr><td></td><td align="center">2</td><td align="center">G308A</td><td align="center">R103Q</td><td align="center">1</td><td></td><td align="center">rs8191613</td></tr><tr><td></td><td align="center">2</td><td align="center">C367A</td><td align="center">P123T</td><td align="center">1</td><td align="center">0</td><td></td></tr><tr><td></td><td align="center">3</td><td align="center">A564G</td><td></td><td align="center">&#x0003e;10</td><td></td><td align="center">rs8191642</td></tr><tr><td></td><td align="center">IVS3</td><td align="center">C689-13T</td><td></td><td align="center">&#x0003e;10</td><td></td><td align="center">rs8191663</td></tr><tr><td></td><td align="center">4 </td><td align="center">G770T </td><td align="center">R257L</td><td align="center">1 </td><td></td><td align="center">rs8191664 </td></tr><tr><td></td><td align="center">3' UTR</td><td align="center">C999+21T</td><td></td><td align="center">&#x0003e;10</td><td></td><td align="center">rs1534862</td></tr><tr><td></td><td align="center">3'UTR</td><td align="center">999+34 delC</td><td></td><td align="center">&#x0003e;10</td><td></td><td align="center">rs8191667</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="center"><italic>MPG</italic></td><td align="center">5' UTR</td><td align="center">1&#x02013;27 insT</td><td></td><td align="center">1</td><td></td><td align="center">rs3176380</td></tr><tr><td></td><td align="center">2</td><td align="center">C147G</td><td></td><td align="center">3</td><td></td><td align="center">rs2259275</td></tr><tr><td></td><td align="center">3</td><td align="center">C342G</td><td></td><td align="center">1</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="center"><italic>TDG</italic></td><td align="center">IVS2</td><td align="center">A166+12G</td><td></td><td align="center">4</td><td></td><td align="center">rs3829300</td></tr><tr><td></td><td align="center">IVS2</td><td align="center">G167-9A</td><td></td><td align="center">&#x0003e;10</td><td></td><td align="center">rs3751209</td></tr><tr><td></td><td align="center">IVS2</td><td align="center">G167-19C</td><td></td><td align="center">1</td><td></td><td></td></tr><tr><td></td><td align="center">3</td><td align="center">A196G</td><td align="center">R66G</td><td align="center">1</td><td align="center">0</td><td></td></tr><tr><td></td><td align="center">10</td><td align="center">G1099 A</td><td align="center">V367M</td><td align="center">&#x0003e;10</td><td></td><td align="center">rs2888805</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="center"><italic>UNG</italic></td><td align="center">2</td><td align="center">C262T</td><td align="center">R88C</td><td align="center">1</td><td align="center">0</td><td></td></tr><tr><td></td><td align="center">2</td><td align="center">G246C</td><td></td><td align="center">0</td><td align="center">1</td><td></td></tr><tr><td></td><td align="center">IVS4</td><td align="center">533&#x02013;25</td><td></td><td align="center">&#x0003e;10</td><td></td><td align="center">rs3219235</td></tr><tr><td></td><td align="center">IVS6</td><td align="center">801+20 delTTTT</td><td></td><td align="center">&#x0003e;10</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="center">SMUG1</td><td align="center">1</td><td align="center">G44T</td><td align="center">G15V</td><td align="center">1</td><td></td><td align="center">rs2233920</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Sequences of primers and PCR conditions used to screen BER genes.</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td></td><td align="center" colspan="2"><bold>Primer sequence (5' &#x0003e; 3')</bold></td><td></td><td></td></tr><tr><td align="center"><bold>Gene</bold></td><td align="center"><bold>Fragment</bold></td><td align="center"><bold>Forward</bold></td><td align="center"><bold>Reverse</bold></td><td align="center"><bold>Amplicon (bp)</bold></td><td align="center"><bold>PCR Conditions*</bold></td></tr></thead><tbody><tr><td align="center"><bold><italic>NTHL1</italic></bold></td><td align="center">1</td><td align="left">GTAGTTCTGTGCCGCCCTCT</td><td align="left">CAGCCTGCAGCCCCTATC</td><td align="center">270</td><td align="center">68&#x02013;60 TD, 1.7M B</td></tr><tr><td></td><td align="center">2A</td><td align="left">ATGAACGAGTGAGGGGTGAG</td><td align="left">AGCTGTTGCTGCCAGTCC</td><td align="center">244</td><td align="center">68&#x02013;60 TD, 1.7M B</td></tr><tr><td></td><td align="center">2B</td><td align="left">AGAGACTGCGTGTGGCCTAT</td><td align="left">GAGGGTGCCAGCCAAAAG</td><td align="center">284</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">3</td><td align="left">CAGGGAATCACCCAGGAC</td><td align="left">AGGTCTCTCTCAGGCCACTG</td><td align="center">279</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">4</td><td align="left">GCTGCATCCTCCCAGGTT</td><td align="left">CACAGGTCACAAGGATGTGG</td><td align="center">298</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td align="center">5</td><td align="left">GGCTAGGCTGGTGGAGTGT</td><td align="left">GGGTCAGTGCTGACAGAGG</td><td align="center">225</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td align="center">6</td><td align="left">GGCTTCCTAGGGAGAAGAGC</td><td align="left">GTGGCTTCCTGAAGCGTAAA</td><td align="center">266</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="center"><bold><italic>NEIL1</italic></bold></td><td align="center">1A</td><td align="left">CAGCCGCTACCTCACAAAGT</td><td align="left">GCTGAAGCTGAGATGCGGTA</td><td align="center">232</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td align="center">1B</td><td align="left">CAGCCAGTTTGTGAATGAGG</td><td align="left">CCGTGTAAAAGCGCAGGT</td><td align="center">281</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td align="center">1C</td><td align="left">CCACTGGCCCTGGTCTTC</td><td align="left">TTGGCCAAGAAGGCACTAAG</td><td align="center">295</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">2</td><td align="left">AGGTTCTCTGAGCCCCTCTC</td><td align="left">GCTAGGCAGTGGGGAATGT</td><td align="center">263</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td align="center">3</td><td align="left">GTGCCCACATTCCCCACT</td><td align="left">CTAAGCTGGGGACACCTGAC</td><td align="center">208</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td align="center">4</td><td align="left">CCCAAAGTCTGACCAAGCTC</td><td align="left">CCCCAGGGTTACACAATCAT</td><td align="center">245</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td align="center">5</td><td align="left">GAGCCTGCCCTCTGATCTCT</td><td align="left">GGGGTCTCTGCCTGTGTG</td><td align="center">203</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td align="center">6</td><td align="left">CACTGATCTGGATGGGTGTG</td><td align="left">ATAGGGTGGAGAAGGGTGCT</td><td align="center">210</td><td align="center">60&#x02013;50 TD, 1M B</td></tr><tr><td></td><td align="center">7</td><td align="left">AGCACCCTTCTCCACCCTAT</td><td align="left">CCGCCCTCTTAGGGTAAGG</td><td align="center">238</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td align="center">8</td><td align="left">CCAACCTCTGAACTGCTTTCT</td><td align="left">TAGAGCCAGTTTCTGGGAGTG</td><td align="center">257</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td align="center">9</td><td align="left">CGTGTACAAAGGTGGGAGAAA</td><td align="left">AATTCAGACCCCCAGATGC</td><td align="center">216</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="center"><bold><italic>NEIL2</italic></bold></td><td align="center">1</td><td align="left">TGCTTGGCACCTGTTAAAGA</td><td align="left">CCCTGAGACATATGGGGATAGA</td><td align="center">296</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">2A</td><td align="left">AATATCCGCATTCCCCAGTT</td><td align="left">GGGCGTCTCTCTCCAAATAC</td><td align="center">296</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">2B</td><td align="left">GGGCAGAAGACCCTTGATG</td><td align="left">TGACTATCAGAGCCCACGAA</td><td align="center">254</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">3</td><td align="left">CAGCCACAGGGTGTGCTCT</td><td align="left">TCTGTGGACTCACCCCTTTC</td><td align="center">299</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">4A</td><td align="left">GCCATGTGTCCTTTGTCCTT</td><td align="left">GCCTCTGTAACCCATCTTCG</td><td align="center">290</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">4B</td><td align="left">CGCAGCACACACAGGTCTAC</td><td align="left">CCACATCCTCCTTTCTGGAC</td><td align="center">237</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="center"><bold><italic>MPG</italic></bold></td><td align="center">1</td><td align="left">GGTCCTAGGGGTGCTTCC</td><td align="left">TGGCCTATGCTCTGGCTCT</td><td align="center">254</td><td align="center">68&#x02013;60 TD, 1.7M B</td></tr><tr><td></td><td align="center">2A</td><td align="left">GCTGTCTCCTATTCGGATGC</td><td align="left">CCCTTTGGGCTTGAGAAATA</td><td align="center">248</td><td align="center">68&#x02013;60 TD, 1.7M B</td></tr><tr><td></td><td align="center">2B</td><td align="left">CACACAGCTCGTCCGATG</td><td align="left">CAGTGACAGGCACTTCAGGA</td><td align="center">229</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">3A</td><td align="left">TGGGCACTGTTAGGGTGAGT</td><td align="left">ACCCTGGCTGGAGATGTTC</td><td align="center">273</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">3B</td><td align="left">CTAGTCCGGCGACTTCCTAA</td><td align="left">CCCCACCTCAGTCCTCCTA</td><td align="center">291</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">4A</td><td align="left">GCAGAGAGGACAGGAGCCTA</td><td align="left">CCAGCCATACAGCTTCATCC</td><td align="center">267</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">4B</td><td align="left">GAGACCATGCGTCAGCTTC</td><td align="left">ACATAGAAGCGGAGGGGTTT</td><td align="center">266</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">4C</td><td align="left">GATGAAGCTGTATGGCTGGAG</td><td align="left">GCTCTGGCTAAGGCACAGTT</td><td align="center">270</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="center"><bold><italic>TDG</italic></bold></td><td align="center">1</td><td align="left">TCTCTGGGGTTGTCTTACCG</td><td align="left">AGCCTGCCCAGCAGTGAG</td><td align="center">180</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">2</td><td align="left">TGATCATTTGGATTTACATTTGG</td><td align="left">GGCTGATCCGATGTTGAACT</td><td align="center">252</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">3A</td><td align="left">TTTTCTGGGAAAGCTGCTAAA</td><td align="left">GGGGAGAGTCTTGGTCAGAA</td><td align="center">279</td><td align="center">60&#x02013;50 TD</td></tr><tr><td></td><td align="center">3B</td><td align="left">CTGGCAAGTCTGCAAAATCA</td><td align="left">GGTCCTTTTCAGCAAAATGC</td><td align="center">252</td><td align="center">60&#x02013;50 TD</td></tr><tr><td></td><td align="center">4</td><td align="left">GATGAAATGTCTAATTGTTTTGTTTT</td><td align="left">CACACAGAACATGAAACACGA</td><td align="center">233</td><td align="center">60&#x02013;50 TD</td></tr><tr><td></td><td align="center">5</td><td align="left">GGCTGCACTGAGCCATGAT</td><td align="left">GGTTCCAACCCATAAAAGCA</td><td align="center">271</td><td align="center">68&#x02013;50 TD</td></tr><tr><td></td><td align="center">6</td><td align="left">TCAAGCTGAGCTCAACAAATG</td><td align="left">CAAACATATTTACATTGCCCATAA</td><td align="center">262</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td align="center">7</td><td align="left">TCAGCCACGAATAGCAGTGT</td><td align="left">TCACAATGGATAGGACAAATAAGG</td><td align="center">288</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td align="center">8A</td><td align="left">CAAGTTATTAACCCAAATAAAGACAAA</td><td align="left">TGAATAAAAGGAATGAGGACAGTAA</td><td align="center">300</td><td align="center">60&#x02013;50 TD, 1M B</td></tr><tr><td></td><td align="center">8B</td><td align="left">CATCCAGTGCAAGATGTGCT</td><td align="left">CACAAAATGAATAAAAGGAATGAGG</td><td align="center">190</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">9</td><td align="left">CAAGAAAAAGAATTGTTCATGATTTC</td><td align="left">CCTGACCAAACCGTCTTTGA</td><td align="center">267</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td align="center">10</td><td align="left">GGCGATAGAGTAAGACCCAGTC</td><td align="left">GGTTCTACTTGTTGACAACTGCAT</td><td align="center">298</td><td align="center">68&#x02013;60 TD</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="center"><bold><italic>UNG</italic></bold></td><td align="center">1</td><td align="left">AATTGCTGACCGCCACAG</td><td align="left">CCTTCCTCCCCCTTCACC</td><td align="center">262</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">2A</td><td align="left">GGGCTCTTACTGTCCGCTTT</td><td align="left">CTCTGGATCCGGTCCAACT</td><td align="center">240</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">2B</td><td align="left">GACCACTTGCAGGCCATC</td><td align="left">GGCCGGCTACACTAACAAGA</td><td align="center">296</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">3</td><td align="left">TTGAATTCTTATGGTTTCCAATGA</td><td align="left">TGTGGCTTAACTCCAGTGTCC</td><td align="center">240</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">4</td><td align="left">CAGGGTCTGTGCTGCTTACA</td><td align="left">AACAGTGCCCCAGATAGTCC</td><td align="center">251</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">5A</td><td align="left">CAAGGGCTGGCTGTAACTTC</td><td align="left">TAGCAGTCGCTGGCTTACCT</td><td align="center">218</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">5B</td><td align="left">GGCTTGCTTTCAGTTTGGAG</td><td align="left">CAGCTATGGTGGCTCATGC</td><td align="center">288</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">6</td><td align="left">TGCCTGAGCCTACATTTAACC</td><td align="left">GCAGGGACTCCTAGAATTCTTTA</td><td align="center">299</td><td align="center">60&#x02013;50 TD, 1M B</td></tr><tr><td></td><td align="center">7</td><td align="left">CCACTGCAGCAAGACTCTGT</td><td align="left">GGAACTTCGTAACTGGCAAA</td><td></td><td align="center">60&#x02013;50 TD</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="center"><bold><italic>SMUG1</italic></bold></td><td align="center">1A</td><td align="left">CTCTGTGGCTGAGGGTTGAT</td><td align="left">TTGTAGATGATGCCCACAGG</td><td align="center">233</td><td align="center">68&#x02013;50 TD, 1M B</td></tr><tr><td></td><td align="center">1B</td><td align="left">AGAGCTTCCTGGAGGAGGAG</td><td align="left">AGCCAAGCATCCACCTAGAA</td><td align="center">258</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">2A</td><td align="left">TCTCCAGTTTGAAGCCTTTCAT</td><td align="left">CTCAGCAGGAGTAAGGTTGC</td><td align="center">300</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">2B</td><td align="left">CCACAATCTATGCCCTCTGC</td><td align="left">TCAATCTTTCCTTGGCCACT</td><td align="center">296</td><td align="center">68&#x02013;60 TD, 1M B</td></tr><tr><td></td><td align="center">2C</td><td align="left">TCTTGGGATCTGTGATGCAG</td><td align="left">TTCGAGGTCTTGAATGTGTCC</td><td align="center">286</td><td align="center">68&#x02013;60 TD, 1M B</td></tr></tbody></table><table-wrap-foot><p>* TD, Touchdown &#x000b0;C; B, Betaine</p></table-wrap-foot></table-wrap></sec></back></article> 